Olga Sokolowska

STING Signaling in Cancer Cells: Important or Not?

D. Nowis, Olga Sokolowska, 2017, Archivum Immunologiae et Therapiae Experimentalis.

Immune checkpoint inhibition improves antimyeloma activity of bortezomib and STING agonist combination in Vk*MYC preclinical model

D. Nowis, J. Gołąb, A. Sosnowska, 2022, Clinical and Experimental Medicine.

Inhibition of arginase modulates T-cell response in the tumor microenvironment of lung carcinoma

D. Nowis, J. Gołąb, A. Sosnowska, 2021, Oncoimmunology.

Upregulation of MLK4 promotes migratory and invasive potential of breast cancer cells

D. Nowis, J. Gołąb, D. Plewczyński, 2018, Oncogene.

Inhibition of protein disulfide isomerase induces differentiation of acute myeloid leukemia cells

Dariusz M Plewczynski, D. Nowis, J. Gołąb, 2018, Haematologica.

Neurodevelopmental phenotype caused by a de novo PTPN4 single nucleotide variant disrupting protein localization in neuronal dendritic spines

D. Nowis, R. Płoski, P. Włodarski, 2018, Clinical genetics.

Immune checkpoint inhibition improves antimyeloma activity of bortezomib and STING agonist combination in Vk*MYC preclinical model

D. Nowis, J. Gołąb, A. Sosnowska, 2022, Clinical and Experimental Medicine.